Key Diagnostic Testing Markets

Questions: Discounts, Updates etc.

Pages: 222

Price: $999.00

Publication Date: 2004-12-04

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *

This TriMark Publications report reviews the high-growth market segments for clinical laboratory testing equipment and supplies in the clinical hospital market, using screening reagents and instruments for analysis of individual components in blood, serum or plasma. Further, it examines the subsections of each market segment, including the clinical laboratory and research areas. Activity and trends in the clinical diagnostic market are discussed, including the numbers of institutions using this type of testing, and the factors that influence purchasing activity. Discussion details the trends that have developed that stimulate this market, and offers detailed comments on the patterns of information processing in point-of-care (POC) testing instruments. The study surveys most of the important companies known to be marketing, manufacturing or developing instruments and reagents in the areas selected as high-growth diagnostic markets in the U.S. and worldwide. Each company is discussed in depth, with a section on its history, product line, business and marketing analysis, and a subjective commentary on the company's position in its market and its strategic direction.

Table of Contents

 

 

  • INDEX OF FIGURES

  • Figure 1: Serological and Clinical Course of Acute HBV Infection73
  • Figure 2: Time Course of Serologic Markers in Acute Hepatitis C Infection76


  • INDEX OF TABLES

  • Table 1: Ten Largest Diagnostic Companies Worldwide Revenues and Market Share 200019
  • Table 2: Total Clinical Diagnostics Dollar Volume by Market Segment 200020
  • Table 3: U.S. Market for Clinical Chemistry Dollar Volume by Analyte 200021
  • Table 4: Worldwide Market for Clinical Chemistry Dollar Volume by Analyte 200022
  • Table 5: Worldwide Market for Other Immunoassays Dollar Volume by Analyte 200022
  • Table 6: Worldwide Market for Nucleic Acid Assays for Infectious Disease Dollar Volume by Analyte 200023
  • Table 7: Worldwide Market for Other Nucleic Acid Arrays Dollar Volume by Analyte 200023
  • Table 8: Market for Coagulation Tests Dollar Volume by Region 200024
  • Table 9: Market for Critical Care Tests Dollar Volume by Region 200024
  • Table 10: U.S. Alternate Site Diagnostic Test Dollar Volume by Sector26
  • Table 11: U.S. Clinical Diagnostic POC Testing and Rapid Test Market Segments Dollar Volume27
  • Table 12: Number of Sites by Type Doing In Vitro Diagnostic Testing in the U.S.27
  • Table 13: U.S. Clinical Laboratory Testing Services Revenue and Growth Rates by Segment28
  • Table 14: U.S. Doctor's Office Test Market Revenue and Growth Rate by Segment28
  • Table 15: U.S. Clinical Diagnostic Home Test Market Revenue and Growth Rates by Segments 199928
  • Table 16: U.S. In Vitro Diagnostic Testing Including Reagents, Instruments, Consumables and Controls Total Sales by Segments 199929
  • Table 17: Global Diabetic Population 1995 and 202530
  • Table 18: Worldwide POC Glucose Testing Market Dollar Volume and Growth Rate31
  • Table 19: U.S. Market for POC and Near-Patient Blood Glucose Testing Market Share by Company31
  • Table 20: World Market Share of POC Glucose Monitoring Marketers31
  • Table 21a: Worldwide Market for Rapid Coagulation Testing Dollar Volume 2000-200838
  • Table 21b: U.S. Market for Rapid Coagulation Testing Dollar Volume 2000-200838
  • Table 21c: U.S. Market for Rapid Coagulation POC Testing Dollar Volume 1996-200738
  • Table 22: U.S. Market for POC Cardiac Marker Testing Dollar Volume and Growth Rate 1999-200744
  • Table 23: Drugs of Abuse Screening U.S. Market Size 1998-200753
  • Table 24: National Institute on Drug Abuse Screening Standards Cutoff Levels by Drug and Test Method55
  • Table 25: U.S. POC Drugs of Abuse Testing Market 2001-200756
  • Table 26: Serological Diagnosis of Hepatitis B Virus Infections74
  • Table 27: Lower Detection Limits of HBV DNA Assays75
  • Table 28: U.S. and Global Market for HAV Diagnostic Testing81
  • Table 29: U.S. and Global Market for HBV Diagnostic Testing81
  • Table 30: U.S. and Global Market for HCV Diagnostic Testing82
  • Table 31: Current Assays for HIV Viral Load Testing93
  • Table 32: U.S. and World Markets for HIV Diagnostic Testing94
  • Table 33: U.S. Cholesterol Testing Volume 2000-200799
  • Table 34: Worldwide Market for In Vitro Cancer Marker Products Dollar Volume in 1999 and 2007102
  • Table 35: U.S. Market for Tumor Marker Assays Dollar Volume by Marker 1998-2002103
  • Table 36: Comparison of Costs at "Moderately Complex" and "Waived" CLIA Labs115
  • Table 37: CPT Codes and Reimbursement Amount for Selected Tumor Markers New York and California119
  • Table 38a: POC Testing Versus Laboratory Testing Clinical Outcomes in Diabetic Ketoacidosis121
  • Table 38b: POC Testing Versus Laboratory Testing Clinical Outcomes in ABG Measurements121
  • Table 39: Emergency Room Admissions in the U.S.122
  • Table 40: POC Testing Cost Analysis with Labor Included123
  • Table 41: Cost Analysis for Glucose Testing: POCT versus Central Lab123
  • Table 42: Normal Blood Glucose Values in Fasting State and Two Hours Postprandially131
  • Table 43: Applications for Wireless LAN Technology Present and Future141
  • Table 44: Wireless Hospital Network Access Points Technology Prices Access Points143
  • Table 45: Wireless Hospital Network Access Points Technology Prices Desktop Adapters (One Computer)143
  • Table 46: Wireless Hospital Network Access Points Technology Prices PCMCIA Adapters143

    •  

     

    Other users found this report page using the following search terms: diagnostics point-of-care POC diagnostic market testing test poc share patient volume glucose keydiagnostictestingmarkets

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.